人参五味子汤加减治疗小儿哮喘缓解期的效果分析

目的：评价人参五味子汤加减治疗小儿哮喘缓解期患者的临床效果.方法：将我院2014年08月～2016年01月收治的76例小儿哮喘缓解期患者作为研究对象,采用随机分组方法分为对照组和观察组,对照组给予患者布地奈德混悬液雾化吸入,观察组在对照组的治疗基础上,增加人参五味汤治疗,观察2组小儿哮喘缓解期患者用药前与用药3个月后的免疫球蛋白（IgA、IgM、IgG）的含量.结果：观察组患者的免疫球蛋白IgA、IgM、IgG的含量分别上升为（1.43±0.34bc）g/L、（9.61±1.01bc）g/L、（1.53±1.35bc）g/L,上升幅度大于对照组,p 值小于0.05.结论：人参五味子汤加减治疗小儿哮喘缓解期的效果显著.

Objective： To evaluate the ginseng Schisandra decoction for treatment of children with asthma in remission clinical results of patients. Methods： A hospital in August 2014 - January 2016 were treated 76 cases of pediatric asthma patients in remission for the study, A randomized method is divided into control group and observation group, the control group of patients given budesonide fog inhalation of the observation group in the treatment of the control group based on the increase in the ginseng soup flavors treatment, two groups were observed in children with asthma medication before remission in patients with immunoglobulin treatment after 3 months （IgA, IgM, IgG） levels. Results： The patients with immunoglobulin IgA, IgM, IgG content were increased to （1.43 ± 0.34bc） g / L, （9.61 ± 1.01bc） g / L, （1.53 ± 1.35bc） g / L, rise bigger than in the control group, p value less than 0.05. Conclusion： Ginseng Schisandra decoction for treatment of children with asthma in remission effect is remarkable.